Singapore's CBC, Abu Dhabi's Mubadala raise $315 mln for Hasten Biopharmaceutic | Reuters
Singapore-based healthcare investment firm CBC Group said on Thursday that it and Abu Dhabi sovereign wealth fund, Mubadala Investment Co completed a $315 million fundraising round for Hasten Biopharmaceutic Co Ltd.
The proceeds will be used to fund future acquisitions and business development of pipeline assets, CBC said.
No comments:
Post a Comment